Skip to main content
. Author manuscript; available in PMC: 2009 Mar 24.
Published in final edited form as: J Neurosci. 2008 Sep 24;28(39):9769–9789. doi: 10.1523/JNEUROSCI.2137-08.2008

Table 4.

Numbers of gap junctions in single and double replicas, per cent of Cx45+Cx36 double-labeled gap junctions, and lower and upper confidence intervals (CI) at 95% confidence levels for Cx45-containing gap junctions expressing both connexins.

Observed Percent Lower 95% CI Upper 95% CI
19/191 100.00% 85.4% 100.0%
41/452 91.1% 78.8% 97.0%
60/643 93.8% 84.8% 98.3%
20/224 90.9% 70.8% 98.9%
8/105 80% 44.4% 97.5%
1

Cx45+Cx36-containing gap junctions from three FRIL replicas that were labeled for longer times in both primary and secondary antibodies.

2

Cx45+Cx36-containing gap junctions from the other 15 FRIL replicas.

3

Cx45+Cx36-containing gap junctions, data combined from all 18 FRIL replicas.

4

Cx45+Cx36-containing gap junctions from 11 paired and 1 unpaired hemiplaques, calculated as individual hemiplaques, from one SDS-FRL double-replica.

5

Cx45+Cx36-containing gap junctions from paired matched hemiplaques, calculated as pairs, from one SDS-FRL double-replica. (Not included is the pair with label for Cx45 and Cx36 on one side and neither label on the other side.)